查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423559

到 2030 年靜脈曲張治療市場預測：按產品類型、最終用戶和地區分類的全球分析

Varicose Vein Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球靜脈曲張治療市場規模為 14 億美元，預計預測期內複合年成長率為 8.3%，到 2030 年將達到 24 億美元。

靜脈曲張治療涉及旨在解決和緩解與靜脈曲張相關的症狀的醫療干預措施。靜脈曲張是一種擴大、扭曲的靜脈，通常出現在小腿上，是由靜脈壁或瓣膜變弱或損壞引起的。生活方式的改變，如定期運動、維持健康的體重和抬高雙腿，可以補充這些醫療干預措施。

提高患者意識

患者現在更願意諮詢醫療保健專業人員以進行及時診斷並探索可用的治療方法，從生活方式的改變到微創手術。這種認知的提高延伸到了未經治療的靜脈曲張的醫療後果，例如靜脈功能不全和潰瘍，以及與可見靜脈相關的美容問題。此外，對預防性醫療保健和早期療育的關注鼓勵及時解決靜脈問題，對靜脈曲張治療市場產生積極影響。

高成本

評估靜脈曲張的嚴重程度和根本原因所需的診斷測試（例如超音波影像成像）可能需要專門的設備、熟練的醫療專業人員和多次治療，這會導致更高的成本。保險範圍和報銷政策也會影響靜脈曲張治療的經濟效益。此外，高昂的治療成本對低收入和保險不足的個人產生了不成比例的影響，導致取得和結果方面的差異，阻礙了該市場的規模。

改善醫療基礎設施

醫療設施的進步，例如專門靜脈曲張診所的建立和現代設備的可用性，有助於改善靜脈曲張患者的就診機會並提高護理品質。這些設施整合了最新技術並遵守嚴格的醫療標準，讓患者受益於更安全、更有效的治療。此外，專門從事靜脈疾病的熟練醫療專業人員的存在進一步加強了基礎設施並支持該市場的擴張。

缺乏意識

缺乏症狀會導致診斷和介入的延誤，患者可能直到症狀變得嚴重才尋求醫療協助。由於缺乏公共教育工作以及有關靜脈曲張和現有治療方法的資訊普及有限，這項挑戰進一步加劇。此外，結果，很大一部分人仍然不了解早期療育的重要性，阻礙了這個市場。

COVID-19 的影響

COVID-19 大流行從多個方面對靜脈曲張治療市場產生了負面影響。關閉醫療設施、限制非必要醫療程序以及將醫療資源重新分配給與大流行相關的活動，大大減少了選擇性手術的數量，包括靜脈曲張治療。此外，大流行期間的經濟不確定性和財政限制導致醫療保健支出下降，阻礙了該市場的規模。

靜脈縫合產品領域預計將在預測期內成為最大的領域

由於設計用於閉合或密封受影響的靜脈以解決靜脈功能不全和靜脈曲張的醫療設備範圍廣泛，靜脈縫合產品領域預計將佔據最大佔有率。這些產品在微創治療中發揮重要作用，旨在將血流重定向到更健康的靜脈。此外，這些靜脈縫合產品正在推動微創介入的成長趨勢，為患者提供傳統手術方法的有效替代方案，推動這一領域的擴張。

注射硬化療法預計在預測期內複合年成長率最高

注射硬化療法預計在預測期內複合年成長率最高。在這項技術中，將固化溶液直接注射到受影響的靜脈中，使其崩壞並最終被吸收到體內。這對小靜脈曲張和蜘蛛網狀靜脈曲張特別有效。此外，注射硬化療法因其簡單、負擔得起和門診病人性質而通常受到青睞，使其成為患者和醫療保健提供者的熱門選擇，並推動了這一領域的擴張。

比最大的地區

由於人口老化、生活方式的改變和意識的提高等因素，亞太地區在預測期內佔據了最大的市場佔有率。 Medtronic PLC、Alma Lasers Ltd.、Teleflex Incorporated 和 Boston Scientific 等主要企業正在採用微創手術，如靜脈注射雷射治療 (EVLT)、射頻消融治療 (RFA) 和注射硬化療法。此外，隨著醫療保健系統的不斷發展以及對微創和有效治療的需求持續成長，該市場預計將進一步擴大。

複合年成長率最高的地區：

由於人們對靜脈健康的認知不斷提高，預計歐洲在預測期內的複合年成長率最高。這反映了微創手術的趨勢，例如靜脈注射雷射治療（EVLT）、射頻消融治療（RFA）和注射硬化療法。此外，歐洲患者擴大尋求恢復時間更快的門診選擇，而這些侵入性較小的手術的普及正在推動該地區的成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球靜脈曲張治療市場：依產品

  • 靜脈縫合產品
  • 消融裝置
    • 射頻消融術裝置
    • 雷射消熔裝置
  • 手術產品
  • 其他產品

第6章全球靜脈曲張治療市場：依治療類型

  • 手術結紮/剝離
  • 靜脈消融
  • 注射硬化療法
  • 其他治療類型

第7章全球靜脈曲張治療市場：依最終使用者分類

  • 靜脈診所
  • 門診治療室
  • 醫院
  • 其他最終用戶

第8章全球靜脈曲張治療市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Medtronic PLC
  • Dornier MedTech GmbH
  • Candela Medical
  • Won Tech Co. Ltd
  • Boston Scientific
  • Sciton Inc.
  • El. En SpA Group
  • Alma Lasers Ltd
  • Teleflex Incorporated
  • AngioDynamics Inc.
  • Eufoton SRL
  • Biolitec AG
Product Code: SMRC24793

According to Stratistics MRC, the Global Varicose Vein Treatment Market is accounted for $1.4 billion in 2023 and is expected to reach $2.4 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Varicose vein treatment involves medical interventions aimed at addressing and alleviating the symptoms associated with varicose veins. Varicose veins are enlarged, twisted veins that commonly appear in the legs and result from weakened or damaged vein walls and valves. Lifestyle modifications, such as regular exercise, maintaining a healthy weight, and elevating the legs, can complement these medical interventions.

Market Dynamics:

Driver:

Rising patient awareness

Patients are now more proactive in consulting healthcare professionals for timely diagnosis and exploring available treatment modalities, ranging from lifestyle modifications to minimally invasive procedures. This heightened awareness extends to both the medical implications of untreated varicose veins, such as venous insufficiency and ulceration, and the aesthetic concerns associated with visible veins. Furthermore, the emphasis on preventive healthcare and early intervention has encouraged individuals to address venous issues promptly, fostering a positive impact on the varicose vein treatment market.

Restraint:

High cost

Diagnostic tests such as ultrasound imaging, which are necessary to assess the severity and underlying causes of varicose veins, may require specialized equipment, skilled healthcare professionals, and multiple sessions, leading to higher costs. Insurance coverage and reimbursement policies can also impact the affordability of varicose vein treatment. Moreover, the high cost of treatment can disproportionately affect individuals with lower incomes or inadequate insurance coverage, leading to disparities in healthcare access and outcomes, which is hampering this market size.

Opportunity:

Improving healthcare infrastructure

Advances in medical facilities, including the establishment of specialized vein clinics and the availability of state-of-the-art equipment, contribute to enhanced accessibility and quality of care for individuals with varicose veins. As these facilities integrate modern technologies and adhere to stringent medical standards, patients benefit from safer and more effective interventions. Additionally, the presence of skilled healthcare professionals specializing in venous disorders further strengthens the infrastructure, which is propelling this market's expansion.

Threat:

Lack of awareness

The lack of awareness contributes to delayed diagnosis and intervention, as patients may not seek medical advice until symptoms become severe. The absence of public education initiatives and the limited dissemination of information about varicose veins and available treatment options further exacerbate this challenge. Moreover, as a result, a substantial portion of the population remains uninformed about the importance of early intervention, thereby hindering this market.

Covid-19 Impact

The COVID-19 pandemic has negatively impacted the varicose vein treatment market in several ways. Lockdowns, restrictions on non-essential medical procedures, and the reallocation of healthcare resources to pandemic-related activities led to a significant decline in the number of elective procedures, including varicose vein treatments. Additionally, economic uncertainties and financial constraints during the pandemic resulted in reduced healthcare spending, thereby hampering this market size.

The venous closure products segment is expected to be the largest during the forecast period

The venous closure products segment is estimated to hold the largest share due to a range of medical devices designed to address venous insufficiency and varicose veins by closing or sealing affected veins. These products play a crucial role in minimally invasive treatments that aim to redirect blood flow to healthier veins. Further, these venous closure products contribute to the growing trend of minimally invasive interventions, providing patients with effective alternatives to traditional surgical approaches, which is boosting this segment's expansion.

The injection sclerotherapy segment is expected to have the highest CAGR during the forecast period

The injection sclerotherapy segment is anticipated to have highest CAGR during the forecast period. This technique involves injecting a sclerosing solution directly into the affected veins, causing them to collapse and eventually be absorbed by the body. It is particularly effective for smaller varicose veins and spider veins. Furthermore, injection sclerotherapy is often preferred for its simplicity, affordability, and outpatient nature, making it a popular choice for both patients and healthcare providers, driving this segment's expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to factors such as population aging, lifestyle changes, and increasing awareness. Key players such as Medtronic PLC, Alma Lasers Ltd., Teleflex Incorporated, and Boston Scientific are adopting minimally invasive procedures like endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. In addition, as healthcare systems continue to evolve and the demand for effective, less-invasive interventions persists, this market is poised for further expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to growing awareness of venous health. It reflects a trend toward minimally invasive procedures, such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. Moreover, patients in Europe are increasingly seeking outpatient options with shorter recovery times, contributing to the popularity of these less invasive techniques, which are propelling this region's growth.

Key players in the market

Some of the key players in the Varicose Vein Treatment Market include Medtronic PLC, Dornier MedTech GmbH, Candela Medical, Won Tech Co. Ltd, Boston Scientific, Sciton Inc., El. En SpA Group, Alma Lasers Ltd, Teleflex Incorporated, AngioDynamics Inc., Eufoton SRL and Biolitec AG

Key Developments:

In December 2023, Teleflex Incorporated announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex's Peripheral Access products.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) have approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

Products Covered:

  • Venous Closure Products
  • Ablation Devices
  • Surgical Products
  • Other Products

Treatment Types Covered:

  • Surgical Ligation/Stripping
  • Endovenous Ablation
  • Injection Sclerotherapy
  • Other Treatment Types

End Users Covered:

  • Vein Clinics
  • Ambulatory Care Unit
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Varicose Vein Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Venous Closure Products
  • 5.3 Ablation Devices
    • 5.3.1 Radiofrequency Ablation Devices
    • 5.3.2 Laser Ablation Devices
  • 5.4 Surgical Products
  • 5.5 Other Products

6 Global Varicose Vein Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Surgical Ligation/Stripping
  • 6.3 Endovenous Ablation
  • 6.4 Injection Sclerotherapy
  • 6.5 Other Treatment Types

7 Global Varicose Vein Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Vein Clinics
  • 7.3 Ambulatory Care Unit
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Varicose Vein Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Medtronic PLC
  • 10.2 Dornier MedTech GmbH
  • 10.3 Candela Medical
  • 10.4 Won Tech Co. Ltd
  • 10.5 Boston Scientific
  • 10.6 Sciton Inc.
  • 10.7 El. En SpA Group
  • 10.8 Alma Lasers Ltd
  • 10.9 Teleflex Incorporated
  • 10.10 AngioDynamics Inc.
  • 10.11 Eufoton SRL
  • 10.12 Biolitec AG

List of Tables

  • Table 1 Global Varicose Vein Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 4 Global Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 5 Global Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 6 Global Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 7 Global Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 14 Global Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 16 Global Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 17 Global Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 21 North America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 22 North America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 23 North America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 24 North America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 25 North America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 26 North America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 28 North America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 29 North America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 30 North America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 31 North America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 32 North America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 North America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 34 North America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 35 North America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 North America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 39 Asia Pacific Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 40 Asia Pacific Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 41 Asia Pacific Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 42 Asia Pacific Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 43 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 44 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 45 Asia Pacific Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 46 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 47 Asia Pacific Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 48 Asia Pacific Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 49 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 50 Asia Pacific Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 51 Asia Pacific Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 52 Asia Pacific Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 53 Asia Pacific Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 54 Asia Pacific Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Europe Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Europe Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 57 Europe Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 58 Europe Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 59 Europe Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 60 Europe Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 61 Europe Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 62 Europe Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Europe Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 64 Europe Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 65 Europe Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 66 Europe Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 67 Europe Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 68 Europe Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 70 Europe Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 71 Europe Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Europe Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 South America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 76 South America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 77 South America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 78 South America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 79 South America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 80 South America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 South America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 82 South America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 83 South America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 84 South America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 85 South America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 86 South America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 87 South America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 88 South America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 89 South America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 90 South America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 93 Middle East & Africa Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 94 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 95 Middle East & Africa Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 96 Middle East & Africa Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 97 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 98 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 99 Middle East & Africa Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 100 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 101 Middle East & Africa Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 102 Middle East & Africa Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 103 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 104 Middle East & Africa Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 Middle East & Africa Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 106 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 107 Middle East & Africa Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 108 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)